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AbstrAct
Background: A patent foramen ovale (PFO) is strongly associated with cryptogenic stroke (CS), neurological and other 
phenomena.  The reported prevalence of PFO varies according to the imaging technique used and population studied.  
Purpose:  To measure prospectively, the prevalence of PFO in a cohort of consecutive patients attending for routine “coronary” 
CT angiography using standard, everyday coronary protocols including low-dose prospective ECG gated studies.   
Methods: Standard coronary imaging protocols were used. PFOs were graded according to the classification of Williamson et al.1 
Results: 261 patients were studied. A PFO was identified in 22.6% (11.5% grade 1 (closed flap), 6.5% grade 2 (open flap) and 
4.6% grade 3 (open flap with jet)). A further 6.1% had an atrial septal aneurysm.
Conclusions:   The prevalence of all grades of PFO (22.6%) and open flap PFO (11.1% = grade 2 and 3) with this technique 
compares with 24.3% by trans-oesophageal echocardiography (TOE) and 14.9% by saline contrast echocardiography (SCE)2, 
3 Further comparative studies are required but we believe an open flap PFO or ASA should be identified and recorded during 
cardiac CT.  This approach may identify those at risk of cryptogenic stroke as well as avoid unnecessary tests in stroke patients.
Keywords: Patent foramen ovale; atrial septum; cardiac anatomy; computed tomographic angiography; non-invasive angiography.
Although the primary clinical role of 64 Multi-detector 
coronary CT (64-MDCT) is assessment of the coronary 
arteries, the excellent spatial resolution of the technique 
allows detailed imaging of other cardiac structures during 
a routine “coronary” examination.4 The inter-atrial septum 
(IAS) is one area that lends itself to such investigation, but 
it has been neglected in some otherwise comprehensive 
assessments of non-coronary cardiac CT pathology.5, 6 
 One study has however, looked at the prevalence of patent 
foramen ovale (PFO) in a mixed cohort of research volunteers 
and suspect ischaemic heart disease (IHD) patients using 
retrospective ECG gating –a relatively high dose technique 
by 2010 standards7. We set out to measure prospectively, the 
prevalence of PFO in a cohort of consecutive suspect IHD 
patients attending for routine coronary CT angiography 
using standard, everyday coronary protocols (including use 
of low-dose prospective ECG gated protocols as frequently 
as possible).
The IAS is formed from the union of two separate layers that 
form a flap valve in utero to facilitate the fetal circulation. 
Failure of the flap valve to close after birth can result in a PFO. 
This communication between right (RA) and left (LA) atria 
provides an anatomic substrate for paradoxical embolisation 
of thrombus and is strongly associated with cryptogenic stroke 
(CS).8 An atrial septal aneurysm (ASA) can also occur and is 
associated with both PFO and CS.8 
Methods
The study was approved by the Western HSC Trust Research 
and Development (Ethics) Chair. Data was collected 
prospectively on patients attending for 64-MDCT between 
the 18th June 2009 and 27th February 2010. 
coMputed toMogrAphy 
64-MDCT was performed using a Philips Brilliance 64 system 
(Philips Medical Systems, Eindhoven, Netherlands). Patients 
were monitored on electrocardiogram (ECG) and a 20FG 
intravenous cannula placed in an ante-cubital fossa vein. All 
patients were in sinus rhythm.  After heart rate optimisation 
and sub-lingual administration of 400 micrograms of glyceryl 
tri-nitrate, non-ionic contrast material (Iohexol, Omnipaque © The Ulster Medical Society, 2011.
Prevalence of patent foramen ovale in a consecutive cohort of 261 patients undergoing  
routine “coronary” 64-multi-detector cardiac computed tomography. 73
www.ums.ac.uk
350, GE Healthcare AS, Norway) was injected into the 
vein (90 ml at a flow rate of 5.5 ml/sec followed by a saline 
chaser of 50mls at 5.5 ml/sec). A bolus tracking technique 
was used to determine when contrast density was optimal 
for coronary imaging. Scanning was performed during a 
single breath hold. In patients with a low and stable heart 
rate (<64 beats per minute), prospective ECG triggering 
was used for data acquisition; otherwise retrospective ECG 
gating was used. In all cases, data was obtained at a single 
time point (75% of the R-R wave interval on ECG). Detector 
collimation was 64 x 0.625mm with images reconstructed 
to a slice thickness of 0.6mm. Tube voltage was 120kV with 
a rotation time of 400 msec.  Standard axial images and 2D 
multiplanar reformations were used for image interpretation. 
Coronal oblique projections through the IAS were specifically 
evaluated for the presence of each of the CT criteria for PFO 
outlined below.
clAssificAtion of pfo And AsA
Williamson et al. devised a classification system based in part 
on chart review of 20 patients with PFO who underwent both 
CT and Trans-oesophageal echocardiography (TOE).1 PFO 
anatomy on 64-MDCT was classified by 3 criteria:
1.  A distinct flap at the expected location in the LA (closed 
flap, Figure 1, panel A).
2.  A continuous column of contrast material between the 
septum primum and septum secundum, connecting the 
LA and RA (open flap, Figure 1 panel B).
3.  An open flap plus a jet of contrast material from the 
column into the RA (open flap with jet, Figure 1, panel 
C).
When compared with TOE diagnosis, the positive predictive 
value of criterion 1 alone was 75%, criteria 1 +2 together was 
80% and 1+2+3 together was 100%.1 
ASA was defined as a redundant and hyper-mobile portion of 
the IAS that demonstrated more than 10-mm excursion from 
the centre line (Figure 2, panel A).9 
We also categorised any potential IAS source of cardio-
embolism into medium and high risk according to the 
TOAST (Trial of Org 10172 in Acute Stroke Treatment) 
classification.10
results
The study population consisted of 261 consecutive patients 
of whom 54% were male (mean age 56 years, range 21 to 81 
years) and 46% were female (mean age 57 years, range 36 to 
81 years). Study quality was sufficient for PFO classification 
in all cases. Study quality for coronary imaging was graded 
as excellent in 50%, good in 28%, fair in 16% and poor in 
6%. A low dose prospective ECG triggered protocol was 
used in 38%. Results are displayed in Table 1.  Amongst the 
261 patients, 59 (22.6%) demonstrated a PFO. This could be 
subdivided into 30 (11.5%) with a grade 1 PFO, 17 (6.5%) 
with grade 2 and 12 (4.6%) with grade 3. In total, 29 (11.1%) 
of patients had an open channel between the atria during the 
CT scan (grade 2 or 3 PFO).
An atrial septal aneurysm was identified in 16 (6.1%) patients 
but no jet of contrast from left to right atrium was seen in 
association with this. 
One patient was seen to have an early (1.1cm diameter) left 
atrial myxoma with prominent central vasculature (Figure 2, 
panel B).
Table 2 lists patients with conditions classified by the TOAST 
criteria for medium or high risk of cardiac embolism.10 Of 
note, 17.2% of patients had medium cardio-embolic risk.
discussion
PFO is strongly linked with conditions such as CS, pulmonary 
embolus and more controversially, migraine with aura.8, 11, 12 
Major studies to determine the role of PFO closure devices 
are underway.13 The reported prevalence of PFO depends 
fig 1. panel A. Oblique coronal view: hollow arrow demonstrates closed flap (Grade 1 PFO), left atrium =LA, right atrium =RA. panel 
b. Oblique coronal view: hollow arrow demonstrates open flap (Grade 2 PFO .  panel c. Oblique coronal view: hollow arrow 
demonstrates jet from open flap (Grade 3 PFO).
fig 2. panel A. Axial view with atrial septal aneurysm 
highlighted by hollow arrow, left atrium =LA, right atrium 
=RA. panel b. A small rounded mass is identified over the 
fossa ovalis with a vascular supply (hollow arrow). This proved 
to be a left atrial myxoma.© The Ulster Medical Society, 2011.
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however, on the imaging modality used and the population 
studied. Prevalence based on normal heart autopsy is 27%, 
whilst SCE and TOE yield figures of 14.9% and 24.3% 
respectively in normal adults.2, 3, 14
Prevalence is higher in vulnerable groups; amongst 
migraineurs in the MIST 1 study, a moderate or large PFO 
was detected in 37.7% by SCE, whilst 43.9% of young CS 
patients were demonstrated to have a PFO by TOE.15, 16  TOE 
is regarded as the gold standard imaging technique for PFO 
assessment.17, 18 Recently, real time 3D TOE has proved useful 
in guiding PFO closure device procedures.19
Moving away from echocardiography, only a handful of 
studies of PFO anatomy have been performed on 64-MDCT.1, 
7, 20, 21
Two studies have concentrated on comparing 64-MDCT 
with TOE. Williamson et al. reviewed 214 charts of patients 
attending for 64-MDCT and found 20 who had also 
undergone TOE. Of the six with PFO on TOE, all had grade 
1 or higher PFO by the criteria defined in that study.1 Kim et 
al. retrospectively analysed images from 152 stroke patients 
who had undergone both TOE and CT.  Twenty-six PFOs were 
identified by TOE with 19 of these patients having a grade 3 
(open flap with jet) PFO appearance on CT.20  The authors 
also noted a “channel-like appearance” of the IAS which 
corresponded to  grade 1 (closed flap) and grade 2 (open flap) 
in the Williamson et al. paper. Compared with TOE, the two 
papers combined yield a sensitivity of 67-73%, specificity of 
98-100%, positive predictive value of 91-100% and negative 
predictive value of 85-95% for a grade 3 CT appearance.   
In a more generalised study, CT was compared with TOE 
for detection of cardiac sources of embolism in 137 stroke 
patients.21 Just under a quarter of the patients had PFO, ASA 
or an atrial septal defect identified by TOE.  Overall sensitivity 
of CT was 89% with a positive predictive value of 100% for 
all embolic causes.  The overall prevalence of all 3 grades 
of PFO in our study was 22.6%. We agree with previous 
authors that an open flap with direct communication between 
atria (grades 2 and 3) is more likely to represent clinically 
significant PFO, in which case, the prevalence falls to 11.1%.
study liMitAtions
One major problem with assessing PFO by 64-MDCT is that 
the information is purely anatomical and obtained during a 
breath hold rather than Valsalva manoeuvre. The functional 
and flow information obtained with TOE cannot be emulated.
It is interesting to note that the prevalence of all 3 grades of 
PFO at 22.6% is very similar to TOE and autopsy reference 
data, perhaps some of the closed flaps (11.5%) would open if 
right atrial pressure was elevated. Unfortunately, the rise in 
central venous pressure associated with Valsalva manoeuvre 
or coughing also impedes the passage of intravenous contrast 
to the heart. Unacceptable respiratory motion artefacts would 
also be introduced.
Potentially, cine CT angiography22 could give information 
about directional flow in a PFO and mobility of ASA, but the 
Valsalva manoeuvre problem would remain. 
 The point we wish to stress in this paper is that much useful 
information can be obtained during a routine coronary study 
without additional measures or high dose protocols. 
The prevalence of ASA in our study (6.1%) falls within the 
range seen in TOE studies on non-stroke patients (4-8%) - this 
figure can rise up to 15 - 28% in stroke populations.23, 24 We 
did not observe left to right contrast flow through an aneurysm 
but it is accepted that approximately 33% of adults with ASA 
also have PFO and ASA is considered a medium risk source 
of embolus by TOAST criteria.8,9
current guidelines
The Society of Cardiovascular Computed Tomography 
(SCCT) guidelines on reporting studies state that any [non-
coronary] abnormalities should be described and that cardiac 
chamber shunts are a required element of a comprehensive 
report25 but given that 17.2% of our patients attending for 
routine coronary CT had a medium cardio-embolic risk (open 
flap PFO or ASA) perhaps more emphasis should be placed 
on this requirement.
conclusions
64-MDCT allows accurate assessment of the IAS during 
routine “coronary” examination. We found the prevalence of 
open flap PFO and ASA to be 11.1% and 6.1% respectively 
Table 1. 
Numbers and percentages of patients displaying conditions 
of the inter-atrial septum.
condition
number of 
patients
percentage 
of total
Normal 185 70.9%
Myxoma 1 0.38%
Grade 1 PFO 30 11.5%
Grade 2 PFO 17 6.5%
Grade 3 PFO 12 4.6%
Atrial septal aneurysm 16 6.1%
All PFOs (Grades 1,2 
+3)
59 22.6%
“Open” PFOs (Grades 
2 +3)
29 11.1%
table 1 legend: pfo = patent foramen ovale. Graded by 
Williamson classification1.
Table 2. 
Conditions classified under the TOAST criteria for 
cardioembolic risk. (11)
condition/risk status number of 
patients
percentage 
of total
high-risk source 
Myxoma 1 0.38%
Medium-risk source
Grade 2 or 3 PFO 29 11.1%
Atrial septal aneurysm 16 6.1%
totAl 46 17.6%
table 2 legend: pfo = patent foramen ovale. Graded by 
Williamson classification1.© The Ulster Medical Society, 2011.
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in a population of 261 patients undergoing routine 64-MDCT 
coronary study. Further comparative studies against SCE and 
TOE are required but we believe open flap PFO and ASA 
should be clearly identified and recorded during routine 
coronary CT angiography.  This approach may identify those 
at risk of cryptogenic stroke as well as avoid unnecessary tests 
in stroke patients.
The authors have no conflict of interest.
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